DICE-CRO

Executive Summary

DICE-CRO is a Belgium-based Contract Research Organization (CRO) founded in 2015, offering comprehensive clinical trial services including study design, biostatistics, data management, and medical writing. With deep therapeutic expertise in oncology, neurology, orphan diseases, and other areas, the company supports global drug development for biopharmaceutical clients. As a private company, DICE-CRO has established itself as a reliable partner in the CRO space, leveraging its specialized knowledge to enhance access to medical treatments. The company's focus on quality and flexibility positions it well within the competitive CRO market, though it faces challenges from larger players with broader geographic reach.

Upcoming Catalysts (preview)

• Q3 2026Strategic partnership with mid-size pharma for oncology trials65% success
• Q4 2026Expansion of service offerings into real-world evidence and decentralized trials50% success
• Q2 2026Publication of positive trial results from key client program in neurology40% success